WEIGHT loss jabs could slash the risk of asthmatics suffering an attack by up to 40 per cent, research suggests. Semaglutide - the powerful ingredient behind Wegovy and Ozempic - has long been hailed a monumental breakthrough in the war on obesity. Yet, mounting evidence has emerged in recent years to suggest the drugs, known...
Back to Top News
Top
September 7, 2026 at 10:01 PM
Fat jabs could slash risk of killer asthma attacks up to 40%, study suggests
The Sun